drugset / Trial / NCT00967772
The Safety/Tolerability and Pharmacokinetics (PKs) of Naftopidil in Korean Healthy Male Volunteers
Parallel-groupSingle-blindBasic science
Summary
The safety/tolerability and pharmacokinetics (PK) of Naftopidil (commercial name: Flivas) after oral administration will be investigated in Korean healthy male volunteers. All volunteers will be assigned to 2 groups and administered a lower single dose tablet (Period 1). After one week's wash-over period, the volunteers take higher dosages (Period 2).
Timeline
- Start
- 2009-09
- Primary completion
- 2009-10
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naftopidil | Small molecule | 25 mg | Oral |
| Subject | Naftopidil | Small molecule | 50 mg | Oral |
| Subject | Naftopidil | Small molecule | 75 mg | Oral |
Indications
No indication recorded.